Dr Rosalind Eggo
Assistant Professor
I work as an infectious disease modeller in public health epidemiology. I received my PhD in infectious disease modelling from Imperial College London, and worked at The University of Texas at Austin, before joining the School in May 2015.
My general research interests are in the role of population heterogeneity in epidemics, and vaccination planning and evaluation. I work on influenza, respiratory viruses, Ebola virus disease, zika, and theoretical aspects of disease transmission and control.
As well as research, I enjoy communicating science to people, and have participated in many outreach activities, such as contributing to the Royal Institution Christmas Lectures in 2019, doing a talk at TEDxThessaloniki in 2018 (video here), and other sorts of activities (Let's play video, RI Apocalypse event, Web App for modelling).
Affiliations
Centres
Teaching
I completed Module 1 of PGCILT in 2018, and am an Associate Fellow of the HEA. At LSHTM, I teach on modelling short courses, face-to-face modules, and on distance learning courses in mathematical modelling.
I am one of three short-course organisers of a new 3-day short course in modelling in R: https://www.lshtm.ac.uk/study/courses/short-courses/modern-techniques-disease-modelling
I supervise MSc student summer projects in modelling, usually from MSc Epidemiology, but also CID, and Med Stats.
I also supervise 3 excellent PhD students. Please contact me if you are looking to do a PhD in modelling.
Research
My work involves studying how infectious diseases spread between individuals, and how to design efficient vaccination strategies to mitigate outbreaks and epidemics.
In 2018 I received an HDR UK Innovation Fellowship, to study the dynamics of respiratory viruses and the impact on those with chronic lung diseases like asthma and COPD.
I also study the transmission of Ebola virus disease, especially examining recent outbreaks such as in West Africa and DRC. I develop models that can help determine optimal vaccination deployment schemes in the event of a new EVD outbreak, as well as methods for assessing new vaccines during outbreaks.
